Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Baker, LCJ"'
BACKGROUND: Hypoxia-inducible factor-1 (HIF-1) mediates the transcriptional response to hypoxic stress, promoting tumour progression and survival. This study investigated the acute effects of the small-molecule HIF-pathway inhibitor NSC-134754. METHO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03892ee274e6d5ba09d48db044dc3af1
https://www.repository.cam.ac.uk/handle/1810/308095
https://www.repository.cam.ac.uk/handle/1810/308095
Autor:
Baker LCJ; Division of Radiotherapy & Imaging, The Institute of Cancer Research, London, United Kingdom., Sikka A; Division of Radiotherapy & Imaging, The Institute of Cancer Research, London, United Kingdom., Price JM; Division of Radiotherapy & Imaging, The Institute of Cancer Research, London, United Kingdom., Boult JKR; Division of Radiotherapy & Imaging, The Institute of Cancer Research, London, United Kingdom., Lepicard EY; Division of Radiotherapy & Imaging, The Institute of Cancer Research, London, United Kingdom., Box G; Division of Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom., Jamin Y; Division of Radiotherapy & Imaging, The Institute of Cancer Research, London, United Kingdom., Spinks TJ; Division of Radiotherapy & Imaging, The Institute of Cancer Research, London, United Kingdom., Kramer-Marek G; Division of Radiotherapy & Imaging, The Institute of Cancer Research, London, United Kingdom., Leach MO; Division of Radiotherapy & Imaging, The Institute of Cancer Research, London, United Kingdom., Eccles SA; Division of Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom., Box C; Division of Radiotherapy & Imaging, The Institute of Cancer Research, London, United Kingdom.; Division of Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom., Robinson SP; Division of Radiotherapy & Imaging, The Institute of Cancer Research, London, United Kingdom.
Publikováno v:
Frontiers in oncology [Front Oncol] 2018 Jul 23; Vol. 8, pp. 271. Date of Electronic Publication: 2018 Jul 23 (Print Publication: 2018).
Autor:
Panek R; CR-UK and EPSRC Cancer Imaging Centre, London, United Kingdom.; Institute of Cancer Research, London, United Kingdom.; Royal Marsden Hospital, London, United Kingdom., Welsh L; Institute of Cancer Research, London, United Kingdom.; Royal Marsden Hospital, London, United Kingdom., Baker LCJ; CR-UK and EPSRC Cancer Imaging Centre, London, United Kingdom.; Institute of Cancer Research, London, United Kingdom., Schmidt MA; CR-UK and EPSRC Cancer Imaging Centre, London, United Kingdom.; Institute of Cancer Research, London, United Kingdom.; Royal Marsden Hospital, London, United Kingdom., Wong KH; Institute of Cancer Research, London, United Kingdom.; Royal Marsden Hospital, London, United Kingdom., Riddell AM; CR-UK and EPSRC Cancer Imaging Centre, London, United Kingdom.; Institute of Cancer Research, London, United Kingdom.; Royal Marsden Hospital, London, United Kingdom., Koh DM; CR-UK and EPSRC Cancer Imaging Centre, London, United Kingdom.; Institute of Cancer Research, London, United Kingdom.; Royal Marsden Hospital, London, United Kingdom., Dunlop A; Institute of Cancer Research, London, United Kingdom.; Royal Marsden Hospital, London, United Kingdom., Mcquaid D; Institute of Cancer Research, London, United Kingdom.; Royal Marsden Hospital, London, United Kingdom., d'Arcy JA; CR-UK and EPSRC Cancer Imaging Centre, London, United Kingdom.; Institute of Cancer Research, London, United Kingdom.; Royal Marsden Hospital, London, United Kingdom., Bhide SA; Institute of Cancer Research, London, United Kingdom.; Royal Marsden Hospital, London, United Kingdom., Harrington KJ; Institute of Cancer Research, London, United Kingdom.; Royal Marsden Hospital, London, United Kingdom., Nutting CM; Royal Marsden Hospital, London, United Kingdom., Hopkinson G; Royal Marsden Hospital, London, United Kingdom., Richardson C; Royal Marsden Hospital, London, United Kingdom., Box C; Institute of Cancer Research, London, United Kingdom., Eccles SA; Institute of Cancer Research, London, United Kingdom., Leach MO; CR-UK and EPSRC Cancer Imaging Centre, London, United Kingdom. martin.leach@icr.ac.uk.; Institute of Cancer Research, London, United Kingdom.; Royal Marsden Hospital, London, United Kingdom., Robinson SP; CR-UK and EPSRC Cancer Imaging Centre, London, United Kingdom.; Institute of Cancer Research, London, United Kingdom., Newbold KL; Institute of Cancer Research, London, United Kingdom.; Royal Marsden Hospital, London, United Kingdom.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2017 Aug 01; Vol. 23 (15), pp. 4233-4241. Date of Electronic Publication: 2017 Mar 17.
Autor:
Baker LCJ; Cancer Research UK Cancer Imaging Centre, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London SM2 5NG, UK., Boult JKR; Cancer Research UK Cancer Imaging Centre, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London SM2 5NG, UK., Thomas M; Roche Pharma Research and Early Development (pRED), Roche Innovation Center, Penzberg DE-82377, Germany., Koehler A; Roche Pharma Research and Early Development (pRED), Roche Innovation Center, Penzberg DE-82377, Germany., Nayak T; Roche pRED, Roche Innovation Center, Basel CH-4070, Switzerland., Tessier J; Roche pRED, Roche Innovation Center, Basel CH-4070, Switzerland., Ooi CH; Roche Pharma Research and Early Development (pRED), Roche Innovation Center, Penzberg DE-82377, Germany., Birzele F; Roche Pharma Research and Early Development (pRED), Roche Innovation Center, Penzberg DE-82377, Germany., Belousov A; Roche Pharma Research and Early Development (pRED), Roche Innovation Center, Penzberg DE-82377, Germany., Zajac M; Roche pRED, Roche Innovation Center, Welwyn AL7 1TW, UK., Horn C; Roche pRED, Roche Innovation Center, Basel CH-4070, Switzerland., LeFave C; Roche pRED, Roche Innovation Center, New York, NY 10016, USA., Robinson SP; Cancer Research UK Cancer Imaging Centre, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London SM2 5NG, UK.
Publikováno v:
British journal of cancer [Br J Cancer] 2016 Sep 06; Vol. 115 (6), pp. 691-702. Date of Electronic Publication: 2016 Aug 16.